The TGen Clinical Research Services, set to open Oct. 24, will include a Genomics Medicine and
TGen said that additional clinical research programs focused on other cancer types are planned in the near future.
Daniel Von Hoff, TGen's senior investigator and director of the Translational Drug Development Division, will serve as medical research leader of TCRS. As the new program grows it is expected to move into a larger space in the Cancer Center's adjoining Research Pavilion, TGen said.
Von Hoff said the alliance "will allow molecular and genomic discoveries made by TGen and others around the world to reach the patient bedside as quickly as possible."